Literature DB >> 9184639

Permeability of the blood-brain and blood-spinal cord barriers to interferons.

W Pan1, W A Banks, A J Kastin.   

Abstract

Interferons (IFNs) are cytokines that produce effects in the CNS even though their production occurs mainly in the periphery. Direct passage of IFNs from blood to CNS could be an important route by which circulating IFNs exert their central effects. In this report, we characterize the pharmacokinetics of the passage of IFNs through the blood-brain and blood-spinal cord barriers in four separate regions: whole brain and the cervical, thoracic and lumbosacral segments of the spinal cord. We found that the spinal cord had greater permeability to IFNs than did the brain. For each corresponding region, the permeability to IFN alpha was higher than that to IFN gamma. Capillary depletion after cardiac perfusion showed that most of the injected IFN was not entrapped by the vasculature but entered the parenchyma of the brain. HPLC showed that most of the IFN gamma entered in intact form. The passage of radioactively labeled IFN gamma into the brain and cervical spinal cord was saturated by a low dose of unlabeled IFN gamma, while passage into the thoracic and lumbosacral spinal cord was not saturated. In contrast, for another cytokine, tumor necrosis factor alpha (TNF alpha), a saturable transport system was present in distal spinal cord as well as the brain. The results show that IFNs and TNF alpha can enter the CNS from the periphery but with regional differences.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184639     DOI: 10.1016/s0165-5728(97)00034-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  58 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

2.  Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.

Authors:  Xiaojun Wu; Hung Hsuchou; Abba J Kastin; Yi He; Reas S Khan; Kirsten P Stone; Michael S Cash; Weihong Pan
Journal:  Psychoneuroendocrinology       Date:  2010-08-17       Impact factor: 4.905

Review 3.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

4.  The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Authors:  N N Spirin; D S Kasatkin
Journal:  Neurosci Behav Physiol       Date:  2009-01

5.  Microglia-dependent synapse loss in type I interferon-mediated lupus.

Authors:  Allison R Bialas; Jessy Presumey; Abhishek Das; Cees E van der Poel; Peter H Lapchak; Luka Mesin; Gabriel Victora; George C Tsokos; Christian Mawrin; Ronald Herbst; Michael C Carroll
Journal:  Nature       Date:  2017-06-14       Impact factor: 49.962

6.  Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.

Authors:  Charles L Raison; Andrey S Borisov; Matthias Majer; Daniel F Drake; Giuseppe Pagnoni; Bobbi J Woolwine; Gerald J Vogt; Breanne Massung; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

7.  Interferon-γ as a Potential Link between Diabetes Mellitus and Dementia.

Authors:  Danielle Cozachenco; Maria C Selles; Felipe C Ribeiro
Journal:  J Neurosci       Date:  2019-06-12       Impact factor: 6.167

8.  Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Balazs Csernus; Abba J Kastin
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS.

Authors:  Weihong Pan; Hung Hsuchou; Chuanhui Yu; Abba J Kastin
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

Review 10.  Cytokine transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.